Agree on this. If you clearly can't forecast reasonably accurately it is not in your interest to do so. Another company I am invested in AJX, went from virtually zero revenues to $14mill in one year, yet they forecast $24mill and have subsequently been punished.
It is extremely difficult for any fledgling company beginning its first revenue stream to accurately gauge revenues. There are so many variables that can significantly alter the forecasts. Forecasting only once repetitive and sustainable revenue flows are evident is the sensible thing to do.
- Forums
- ASX - By Stock
- WFL
- BodyGuard Life Science -Website Under Maintenance!
BodyGuard Life Science -Website Under Maintenance!, page-112
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
WFL (ASX) Chart |
Day chart unavailable